[Twice daily irradiation of nasopharyngeal lymphosarcomas and cancer].
The authors present the preliminary results of double daily irradiation with a 4-hour interval of patients with rhinopharyngeal cancer (30 persons) and lymphosarcoma (18). This irradiation variant was well tolerated; all the patients received radiotherapy in accordance with the plan of irradiating tumors with mean focal doses of 70-76 Gy for rhinopharyngeal cancer and 40-50 Gy for lymphosarcoma. Complete tumor regression by the end of radiotherapy was achieved in 75%, partial in 25% of patients with rhinopharyngeal cancer. In lymphosarcoma, these figures were 80 and 20%, respectively. No late injuries of the normal tissues after 6-36 months were noted in patients.